skip to main content
Idioma:
Result Number Material Type Add to My Shelf Action Record Details and Options
1
24P Sinonasal neuroendocrine tumors: Analysis of therapeutic strategies in an ultra-rare tumor
24P Sinonasal neuroendocrine tumors: Analysis of therapeutic strategies in an ultra-rare tumor
Material Type:
Artigo 		Adicionar ao Meu Espaço

24P Sinonasal neuroendocrine tumors: Analysis of therapeutic strategies in an ultra-rare tumor

Sanz, S. Barriendos ; Pascual de La Fuente, N. ; Mugarza, P.G. ; Cepero, M.L. Monreal ; Ramirez, S.E. Campos ; Campillo, F. Mocha ; Cobos, P. Trincado ; Egea, S.E. Ruffini ; Orce, A.M. Comín ; Trufero, J. Martinez

ESMO open, 2024-03, Vol.9, p.102412, Article 102412 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
2
3. Primo Levi et le difficile rapport avec la population italienne
3. Primo Levi et le difficile rapport avec la population italienne
Material Type:
Artigo 		Adicionar ao Meu Espaço

3. Primo Levi et le difficile rapport avec la population italienne

Ruffini, Elisabetta

Revue d’Histoire de la Shoah, 2017-08, Vol.206 (1), p.63-83 [Periódico revisado por pares]

Mémorial de la Shoah

Texto completo disponível

Citações Citado por
3
75P Review of the systemic treatment of leiomyosarcomas in a Spanish reference center in the last 10 years
75P Review of the systemic treatment of leiomyosarcomas in a Spanish reference center in the last 10 years
Material Type:
Artigo 		Adicionar ao Meu Espaço

75P Review of the systemic treatment of leiomyosarcomas in a Spanish reference center in the last 10 years

Ramirez, S.E. Campos ; Egea, S.E. Ruffini ; Cepero, M.L. Monreal ; Mugarza, P.G. ; Sanz, S. Barriendos ; Cobos, P. Trincado ; Campillo, F. Mocha ; Pascual de La Fuente, N. ; Trufero, J. Martinez ; Lobera, M.P. Felices

ESMO open, 2024-03, Vol.9, p.102465, Article 102465 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Abstract C22: A phase Ib study of the CXCR1/2 inhibitor Reparixin in combination with weekly paclitaxel in metastatic HER2 negative breast cancer - final analysis
Abstract C22: A phase Ib study of the CXCR1/2 inhibitor Reparixin in combination with weekly paclitaxel in metastatic HER2 negative breast cancer - final analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abstract C22: A phase Ib study of the CXCR1/2 inhibitor Reparixin in combination with weekly paclitaxel in metastatic HER2 negative breast cancer - final analysis

Schott, Anne F. ; Wicha, Max S. ; Perez, Raymond P. ; Kato, Giraldo ; Avery, Tiffany ; Cristofanilli, Massimo ; Reuben, James M. ; Alpaugh, R. Katherine ; Ruffini, Pier Adelchi ; Mccanna, Susan ; Goldstein, Lori J.

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.C22-C22 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Abstract CT057: A single-arm, preoperative, pilot study to evaluate the safety and biological effects of orally administered reparixin in early breast cancer patients who are candidates for surgery
Abstract CT057: A single-arm, preoperative, pilot study to evaluate the safety and biological effects of orally administered reparixin in early breast cancer patients who are candidates for surgery
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abstract CT057: A single-arm, preoperative, pilot study to evaluate the safety and biological effects of orally administered reparixin in early breast cancer patients who are candidates for surgery

Goldstein, Lori J. ; Perez, Raymond P. ; Yardley, Denise A. ; Han, Linda K. ; Reuben, James M. ; McCanna, Susan ; Butler, Beth ; Ruffini, Pier Adelchi ; Chang, Jenny C.

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT057-CT057 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Abstract OT1-03-07: A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for triple-negative breast cancer (fRida)
Abstract OT1-03-07: A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for triple-negative breast cancer (fRida)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abstract OT1-03-07: A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for triple-negative breast cancer (fRida)

Chang, JC ; Schott, AF ; Wicha, MS ; Cristofanilli, M ; Ruffini, PA ; McCanna, S ; Goldstein, LJ

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.OT1-03-07-OT1-03-07 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Abstract OT2-3-01: Phase Ib pilot study to evaluate reparixin in combination with chemotherapy with weekly paclitaxel in patients with HER-2 negative metastatic breast cancer (MBC)
Abstract OT2-3-01: Phase Ib pilot study to evaluate reparixin in combination with chemotherapy with weekly paclitaxel in patients with HER-2 negative metastatic breast cancer (MBC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abstract OT2-3-01: Phase Ib pilot study to evaluate reparixin in combination with chemotherapy with weekly paclitaxel in patients with HER-2 negative metastatic breast cancer (MBC)

Schott, AF ; Wicha, M ; Cristofanilli, M ; Ruffini, P ; McCanna, S ; Reuben, JM ; Goldstein, LJ

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.OT2-3-01-OT2-3-01 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Abstract OT2-6-03: A single arm, preoperative, pilot study to evaluate the safety and biological effects of orally administered reparixin in early breast cancer patients who are candidates for surgery
Abstract OT2-6-03: A single arm, preoperative, pilot study to evaluate the safety and biological effects of orally administered reparixin in early breast cancer patients who are candidates for surgery
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abstract OT2-6-03: A single arm, preoperative, pilot study to evaluate the safety and biological effects of orally administered reparixin in early breast cancer patients who are candidates for surgery

Goldstein, LJ ; Sparano, J ; Perez, RP ; Vito, C ; Reuben, JM ; Landis, MD ; McCanna, S ; Ruffini, PA ; Cristofanilli, M ; Chang, JC

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.OT2-6-03-OT2-6-03 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Abstract P3-11-07: A randomized phase II trial of reparixin, a CXCR1 inhibitor, in combination with paclitaxel in the treatment of mTNBC
Abstract P3-11-07: A randomized phase II trial of reparixin, a CXCR1 inhibitor, in combination with paclitaxel in the treatment of mTNBC
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abstract P3-11-07: A randomized phase II trial of reparixin, a CXCR1 inhibitor, in combination with paclitaxel in the treatment of mTNBC

Goldstein, Lori J ; Mansutti, Mauro ; Levy, Christelle ; Chang, Jenny C ; Henry, Stephanie ; Fernandez-Perez, Isaura ; Viale, Giuseppe ; Viale, Guiseppe ; Butler, Beth ; McCanna, Susan ; Ruffini, Pier A ; Wicha, Max ; Schott, Anne F

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-11-07 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
Abstract P6-03-01: A phase Ib study of the CXCR1/2 inhibitor reparixin in combination with weekly paclitaxel in metastatic HER2 negative breast cancer – First analysis
Abstract P6-03-01: A phase Ib study of the CXCR1/2 inhibitor reparixin in combination with weekly paclitaxel in metastatic HER2 negative breast cancer – First analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abstract P6-03-01: A phase Ib study of the CXCR1/2 inhibitor reparixin in combination with weekly paclitaxel in metastatic HER2 negative breast cancer – First analysis

Schott, Anne F ; Wicha, Max S ; Perez, Raymond P ; Kato, Giraldo ; Avery, Tiffany ; Cristofanilli, Massimo ; Reuben, James M ; Alpaugh, R Katherine ; McCanna, Susan ; Ruffini, Pier Adelchi ; Goldstein, Lori J

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P6-P6-03-01 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (575)
  2. Anais de Congresso  (21)
  3. Book Chapters  (16)
  4. Livros  (12)
  5. magazinearticle  (6)
  6. Reports  (5)
  7. Resenhas  (3)
  8. Conjunto de Dados  (2)
  9. Recursos Textuais  (1)
  10. Dissertações  (1)
  11. Web Resources  (1)
  12. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1974  (19)
  2. 1974Até1988  (27)
  3. 1989Até2001  (39)
  4. 2002Até2012  (104)
  5. Após 2012  (454)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (571)
  2. Francês  (72)
  3. Japonês  (35)
  4. Alemão  (3)
  5. Italiano  (1)
  6. Espanhol  (1)
  7. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Ruffini, R
  2. Ruffini, J
  3. Wheeler, J
  4. Ruffini, V
  5. Sousa, F

Neste Assunto:

  1. Science & Technology
  2. Physical Sciences
  3. Astronomy & Astrophysics
  4. Physics
  5. Gamma Ray Bursts

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.